A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma
Clinical trial NCT03294083 · COMPLETED
Trial details
- NCT number
- NCT03294083
- Sponsor
- SillaJen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-19
- Primary completion
- 2023-02-16
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.